male erectile dysfunction

Is Zoom causing erectile dysfunction in younger men? - THE EDGE SINGAPORE

Healthcare

Is Zoom causing erectile dysfunction in younger men?

With all the anxiety from fear of job loss and the stress of keeping it, sex was probably the furthest thing from our minds last year.

iX Biopharma obtains approval and registration of male erectile dysfunction drug in Singapore - THE EDGE SINGAPORE

Company in the news

iX Biopharma obtains approval and registration of male erectile dysfunction drug in Singapore

iX Biopharma has obtained approval and registration by the Health Sciences Authority (HSA) for Silcap, a sildenafil drug that is used in the treatment of male erectile dysfunction on Oct 20.

ix biopharma

Company in the news

iX Biopharma enters China market with licensing agreement for erectile dysfunction drug

SINGAPORE (Apr 27): iX Biopharma has entered into a 10-year licensing agreement with Yiling Pharmaceutical in China for the licensing, supply, and distribution of Wafesil, a fast-dissolvi

iXBiopharma's Wafesil granted regulatory approval for treatment of male erectile dysfunction in Australia

SINGAPORE (June 19): iX Biopharma says the Australia’s regulatory authority, Therapeutic Goods Administration (TGA), has given the go-ahead for the use of Wafesil to treat of male erectile dysfunct

Broker's Calls

A case of no pain no gain for iX Biopharma

SINGAPORE (Oct 13): DBS Group Research has derived a fair value estimate of 43 cents for iX Biopharma in its preliminary assessment of what it deems a high-risk stock, with a view that investors sh

In print this week

iX Biopharma’s PheoniX rises to Viagra challenge, but will its share price stay up?

SINGAPORE (Sept 16): News that iX Biopharma’s drug to treat male erectile dysfunction is close to appearing on pharmacy shelves has got the market excited.

iX Biopharma’s male erectile dysfunction drug stands up to the test

SINGAPORE (Sept 13): Specialty pharmaceutical company iX Biopharma on Tuesday announced positive results in a pivotal bioequivalence study of its male erectile dysfunction drug.

×